2014/09/09

SHIONOGI PRESENTS PRE-CLINICAL AND PHASE I RESULTS FOR S-649266, A NOVEL SIDEROPHORE CEPHALOSPORINE ANTIBIOTIC WITH POTENTIAL TO TREAT MULTIDRUG-RESISTANT GRAM-NEGATIVE PATHOGENS